Friday, May 9, 2025
Home Authors Posts by Editor / Curator

Editor / Curator

941 POSTS 0 COMMENTS
ibio
Superbug News - CoronaVirus Watch List

Adding iBIO (IBIO) $2.27 to CoronaVirus Watch List.

Editor / Curator -
video
Stand Down.

Stand Down XI. The Best Explanation of What Lies Ahead for...

Editor / Curator -
2020 Watch List

2020 Biotech Portfolio Soars 55%, We’re Amazed.

Editor / Curator -
2020 Watch List

Citius (CTXR) CEO Myron Holubiak Live on TV, 1:20 Today, June...

Editor / Curator -
Stand Down.

How The Housing Crash Will Happen.

Editor / Curator -
Citius Pharma
2020 Watch List

Citius Pharma (CTXR) On The Move.

Editor / Curator -
Biotech Stock Review
Superbug News - CoronaVirus Watch List

Meet The Billion-Dollar Family Company That Makes Purell (Forbes).

Editor / Curator -
Immuron, IMRN
Superbug News - CoronaVirus Watch List

Corona Craziness Continues. Immuron (IMRN) Gains 10-Fold or 1000%, in 3...

Editor / Curator -
Superbug News - CoronaVirus Watch List

Reams of Corona Charts. Global Macro Investor.

Editor / Curator -
Checkpoint Theraputics
Interview

11:00 AM Webinar Today, Checkpoint Therapeutics (CKPT) CEO James Olivero.

Editor / Curator -
1...666768...95Page 67 of 95

Latest article

Zomedica Corp (ZOMDF) $0.05

Uncategorized Editor / Curator -
Company Overview Background Zomedica Corp., incorporated in 2013 under the Business Corporations Act (Alberta), is...

Gold prices plunge in biggest one-day drop in years. Is the record rally over?...

All News Editor / Curator -
Easing anxieties over Trump’s tariff policies and the Fed chair’s fate spark gold’s worst daily decline since 2021 Gold...

Gold Price Sets New Intraday Record Above $3,500 (WSJ)

All News Editor / Curator -
Gold hit another record Tuesday, then faded a bit in afternoon trading. The most actively traded futures contracts surged...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.